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A B S T R A C T   
Background:  Depression is highly heterogeneous in its clinical presentation. Those with attention deficit/hy-
peractivity disorder (ADHD) may be at risk of a more chronic and impairing depression compared to those with 
depression alone according to studies of young people. However, no studies to date have examined ADHD in 
recurrently depressed adults in mid-life. 
Method:  In a sample of women in mid-life (n=148) taken from a UK based prospective cohort of adults with a 
history of recurrent depression, we investigated the prevalence of ADHD and the association of ADHD with 
clinical features of depression. 
Results:  12.8% of the recurrently depressed women had elevated ADHD symptoms and 3.4% met DSM-5 diag-
nostic criteria for ADHD. None of the women reported having a diagnosis of ADHD from a medical professional. 
ADHD symptoms were associated with earlier age of depression onset, higher depression associated impairment, 
a greater recurrence of depressive episodes and increased persistence of subthreshold depression symptoms over 
the study period, higher levels of irritability and increased risk of self-harm or suicide attempt. ADHD symptoms 
were associated with increased risk of hospitalisation and receiving non-first-line antidepressant medication. 
Limitations:  ADHD was measured using a questionnaire measure. We focussed on mothers in a longitudinal study 
of recurrent depression, so the findings may not apply to males or other groups. 
Conclusions:  Higher ADHD symptoms appear to index a worse clinical presentation for depression. Clinical 
implications include that in women with early onset, impairing and recurrent depression, the possibility of 
underlying ADHD masked by depression needs to be considered.   
1. Introduction 
Depression is a highly heterogeneous disorder that varies in its ori-
gins and clinical presentation (Fried and Nesse, 2015; Kendler et al., 
1996; Weissman et al., 1986). Studies of children and adolescents have 
found that individuals with attention deficit/hyperactivity disorder 
(ADHD), a neurodevelopmental disorder, are at higher risk of 
early-onset, recurrent depression compared to those without ADHD 
(Biederman et al., 2008; Riglin et al., 2020). Both epidemiological and 
clinical studies report associations between early onset depression and 
neurodevelopmental disorders and traits, especially ADHD (Biederman 
et al., 2008; Bron et al., 2016; Jaffee et al., 2002; Rice et al., 2019; van Os 
et al., 1997). One four-year follow-up study of depressed adults and 
community controls aged 21 to 69 years found increased odds of having 
probable ADHD in those with longer lasting depressive episodes and in 
those with a reported age of onset of before 21 years old compared to 
onset after 21 (Bron et al., 2016). However, the impact of ADHD on 
different aspects of depression presentation in those with recurrent 
depression in midlife is not known. 
There is evidence to suggest that there is a neurodevelopmental ge-
netic contribution to some forms of depression, including ADHD and 
schizophrenia genetic risk (Lee et al., 2019; Power et al., 2017; Rice 
et al., 2019). For instance, one such study of a population sample fol-
lowed from birth to young adulthood found that an earlier-onset, more 
chronic class of depression was associated with a higher level of neu-
rodevelopmental traits, including ADHD symptoms, ADHD genetic risk 
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and schizophrenia genetic risk (Rice et al., 2019). Another 
population-based study found that ADHD genetic risk was increased in 
those with treatment resistant depression compared to non-treatment 
resistant depression (Fabbri et al., 2021). Those with depression that 
is accompanied by ADHD are a clinically important group as they show 
higher rates of antidepressant treatment resistance, suicide and psy-
chiatric hospitalisation compared to those with depression alone (Bie-
derman et al., 2008, 1996; Chen et al., 2016). ADHD that persists into 
adulthood is associated with more comorbid mental health problems 
(Agnew-Blais et al., 2016; Riglin et al., 2016). However, 
neurodevelopmental disorders that were not identified in childhood can 
be missed in adults, especially among women (Martin et al., 2018). 
There is also emerging evidence to suggest that recurrent adult 
depression may mask underlying neurodevelopmental disorders 
including ADHD that are missed in clinical practice (McIntosh et al., 
2009). However, the rate of ADHD in middle-aged adults with recurrent 
depression in the community and the impact of ADHD on depression 
presentation in this group are unknown. 
In this UK based longitudinal study spanning 13 years, we aim to 
investigate ADHD in women with recurrent depression. First, we 
Fig 1. Study design and participation rates across assessment waves of the EPAD study. The Early Prediction of Adolescent Depression (EPAD) study took place 
over four assessment waves between April 2007 and September 2020 via interview and questionnaire. Numbers of participants reported are those participating at 
each wave via questionnaire, interview or both. Only 262 adults were contactable at wave 4. Reasons for this include loss of up to date contact details, withdrawal 
from the study, death and declining to participate due to ill health, bereavement or other commitments such as work (n=75). Of the 262 contactable participants at 
wave 4, 68 were unresponsive despite multiple communication attempts. 
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investigate the prevalence of ADHD in this group. Next, we investigate a 
number of clinical features of depression potentially associated with 
ADHD including age of onset, severity, episode recurrence, subthreshold 
symptom persistence, suicide and self-harm attempts, psychotic affec-
tive symptoms and irritability symptoms. Additionally, we investigate 
the association of ADHD symptoms with aspects of the clinical man-
agement of depression, including hospitalisation and use of first-line 
versus non-first-line antidepressant medication, as an indicator of poor 
treatment response or a complex clinical presentation. 
2. Method 
2.1. Sample 
Data came from the Early Prediction of Adolescent Depression 
(EPAD) study – a prospective longitudinal study of recurrently depressed 
parents and their offspring based in the UK (Mars et al., 2012). The 
baseline sample included 337 parents with recurrent unipolar depres-
sion (two or more lifetime DSM-IV Major Depressive Disorder (MDD) 
episodes confirmed at interview) and their offspring. Families were 
assessed at 4 time points between April 2007 and September 2020 via 
interview and questionnaire. The average length of follow up was 16 
months between the first and second waves, 13 months between the 
second and third, and 8 years between the third and fourth. The current 
study focuses primarily on the fourth assessment wave, as adult ADHD 
data was collected during this wave. The fourth wave was carried out 
between 2018 and 2020 and 197 families participated. Study design and 
participation rates are summarised in Fig. 1. Reasons for the lower 
retention rate between the third and fourth assessment waves include: 
death of participants, loss to follow-up and withdrawal from the study. 
Of the 197 participating families at wave 4, 159 mothers had data on 
their own ADHD symptoms. Of these 159, 148 women (mean age: 53, 
range: 42 – 67) with complete data on their own ADHD symptoms, 
clinical features of their depression, irritability and sociodemographic 
variables formed the primary sample. Analysis of baseline factors asso-
ciated with drop-out by wave 4 is shown in Supplement 1. Ethical 
approval was granted by the Multi-Centre Research Ethics Committee 
for Wales and from the School of Medicine Ethics Committee, Cardiff 
University. Written informed consent and assent was gained from each 
of the participants at each wave. More detailed information about 
recruitment, assessments and sample characteristics at assessment 
waves 1 to 3 can be found elsewhere (Mars et al., 2015, 2012). 
2.2. Overview of assessment procedure 
The sample was recruited mainly from general practice surgeries in 
South Wales (78%). Additional participants were recruited using a 
database of individuals who had been identified as having previous 
unipolar depression, via community mental health teams and adver-
tisements in local media and primary care centres (Mars et al., 2012). 
The original aim of the study was to conduct a cross-generational study 
to examine the offspring of parents with recurrent depression, so all 
participants had biologically related offspring living at home in the age 
range of 9-17 years at the time of initial recruitment. Recruited adults 
were screened over the telephone to ensure they met inclusion criteria: 
suffered from re-current unipolar depression (at least 2 episodes, which 
were later confirmed using diagnostic interview). Adults were not 
required to be experiencing a depressive episode at the time of recruit-
ment. Adults who had a lifetime diagnosis of bipolar or psychotic dis-
order and those who met criteria for DSM-IV mania or hypomania at the 
time of the interview were excluded. 
At each assessment wave (1 through 4), the Schedule for Clinical 
Assessment (SCAN) (Wing et al., 1990) was used to assess adult DSM-IV 
MDD based on the symptoms and impairment reported in the preceding 
month. All cases meeting criteria for diagnosis in addition to sub-
threshold cases were reviewed by two psychiatrists and diagnoses were 
made according to clinical consensus. At the baseline assessment, par-
ticipants were additionally asked to report on their worst ever and 
second worst ever episodes of depression and associated impairment. 
They were also asked to retrospectively report on various clinical fea-
tures of their depression including first age of onset. A life history cal-
endar approach was used for all retrospectively reported information to 
aid recall (Belli, 1998). At all subsequent assessment waves, participants 
were asked to report on episodes of depression they had experienced 
since the previous assessment wave and to report on associated 
impairment. Participants additionally completed a questionnaire 
booklet which included questions relating to sociodemographic infor-
mation, family structure and relationships, and psychiatric symptom 
measures such as the Beck Depression Inventory (BDI) (Beck et al., 
1961). 
2.3. Measures 
2.3.1. Adult ADHD 
Participants completed the Adult ADHD Investigator Symptom Rat-
ing Scale (AISRS) (Spencer et al., 2009) via questionnaire at wave 4. The 
AISRS consists of 18 items based on the DSM-5 (American Psychiatric 
Association, 2013) symptoms of ADHD. Symptoms were rated on a 
4-point scale of “Never/Rarely” (0), “Sometimes” (1), “Often” (2) and 
“Very often” (3). 
Predictor variables were 1) a total ADHD symptom score (possible 
range: 0-54) and 2) a binary variable of “elevated ADHD symptoms”. 
Those meeting the AISRS clinical cut point by scoring 24 or higher 
(Silverstein et al., 2018) were classed as having elevated ADHD 
symptoms. 
Diagnosis: Participants were also asked to complete a further set of 
questions in the questionnaire if they reported ADHD symptoms: at what 
age they could recall these symptoms starting in approximate years and 
to indicate whether the symptoms impacted on functioning in a number 
of areas of life. For descriptive purposes, participants were classed as 
meeting DSM-5 criteria for adult ADHD diagnosis if they reported at 
least 5 current symptoms, an age of onset of these problems prior to 12 
years old and associated impairment in home, work or social life 
(American Psychiatric Association, 2013). 
During the interview at assessment wave 4, participants were also 
asked to report on their recent and current service use and any diagnoses 
they had received from a medical professional using a questionnaire 
adapted from the Children’s Services Interview (Ford et al., 2007), 
which was used to establish if any participants had received a clinical 
diagnosis of ADHD. 
2.3.2. Clinical features of depression 
2.3.2.1. Age of onset. Participants were asked at baseline interview to 
report the age of onset (in years) of their first MDD episode. Age of onset 
was dichotomised so that onset at 25 years old or earlier was classed as 
early-onset depression based on previous studies (Power et al., 2017). 
2.3.2.2. Severity. Impairment associated with depression was measured 
using the Global Assessment of Functioning (GAF) (American Psychi-
atric Association, 1994), which was assessed for the worst ever episode 
reported by the participant at baseline interview and at each subsequent 
assessment phase for current/recent depression. A binary measure was 
derived capturing whether participants had ever had a GAF score ≤ 50 
during the study period with GAF scores below or equal to 50 indicating 
serious impairment in work or social life (American Psychiatric Asso-
ciation, 1994). 
2.3.2.3. Episode recurrence. A count variable of the recurrence of 
depressive episodes across the study period was derived. This included a 
count of the number of assessment points at which participants met 
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clinical criteria for MDD plus the number of times participants reported 
being depressed since the last assessment wave (possible range=0-7). 
2.3.2.4. Subthreshold persistence. In addition to recurrence of depres-
sion episodes meeting diagnostic criteria, chronicity of subthreshold 
symptoms over time is common and impairing (Fergusson et al., 2005; 
Judd et al., 1998). Thus, as an indicator of persistence of depression 
symptoms over time, self-report questionnaire measures of depressive 
symptoms at waves 1 through 4 were used to derive a measure of sub-
threshold depression persistence. These were the Patient Health Ques-
tionnaire (PHQ) (Kroenke et al., 2001) at waves 1 and 4 and the Beck 
Depression Inventory (BDI) (Beck et al., 1961) at waves 2 and 3 – both 
valid and reliable measures of depressive symptoms (Beck et al., 1988; 
Kroenke et al., 2001; Strober et al., 1981). Depressive symptom scores 
were calculated at each wave. Those falling into the “intermediate” 
symptoms group (between the “none/mild” and “severe” group: scoring 
5-19 on the PHQ or 10-29 on the BDI) were defined at each wave based 
on the cut points validated for the PHQ and BDI (Beck et al., 1988; 
Kroenke et al., 2001). A count of the number of times symptoms were of 
the intermediate level was derived (possible range=0-4). 
2.3.2.5. Suicide and self-harm attempt. The SCAN (Wing et al., 1990) 
was used to assess self-harm or suicide at each wave with the question 
“Have you thought about harming yourself or even made an attempt at 
suicide during the last month?”. Participants responses were coded as 
‘absent’ (0), ‘intrusive thoughts but no attempt’ (1), ‘injured self but no 
serious harm resulted’ (2), ‘injured self and serious harm resulted’ (3) or 
‘made an attempt at suicide designed to result in death’ (4). A binary 
variable capturing whether participants had ever reported self-harm or 
suicide attempts (scored 2 or more) at any of the four assessment waves 
was derived. 
2.3.2.6. Psychotic affective symptoms. A binary variable capturing 
whether participants had ever endorsed psychotic affective symptoms 
during the SCAN (Wing et al., 1990) at waves 1 to 4 was derived. Psy-
chotic affective symptoms assessed were delusions of guilt, delusions of 
catastrophe, hypochondriacal delusions and auditory hallucinations. 
2.3.2.7. Irritability. Participants completed the Affective Reactivity 
Index (ARI) (Stringaris et al., 2012) via questionnaire at wave 4. Though 
it was developed to assess irritability in children and adolescents, it has 
been shown to be a reliable and valid measure in adult samples 
(Stringaris et al., 2012). The ARI consists of 7 items with responses of 
“Not true” (0), “Somewhat true” (1) or “Certainly true” (2), which are 
summed to give a total score (possible range=0-14). 
2.3.2.8. Hospitalisations. Participants reported the number of times 
they had ever been hospitalised due to depression at baseline, and the 
number of times they had been hospitalised since the last assessment 
wave at waves 2 and 3. At wave 4, participants were not asked explicitly 
to report the number of hospitalisations, but they were asked to give 
details of what happened during any depressive episodes experienced 
since the last wave, which gave an opportunity to disclose hospital-
isations. From this information, a binary variable was derived capturing 
whether participants had ever been hospitalised due to depression. 
2.3.2.9. Antidepressant medication. At wave 4, participants reported 
what medication they were currently taking, including medication for 
depression. Based upon UK National Institute for Health and Care 
Excellence (NICE) clinical guidelines for management of adult depres-
sion and the British National Formulary (BNF) (Joint Formulary Com-
mittee, n.d.; National Institute for Health and Care Excellence (NICE), 
2009), a binary variable of no depression treatment or first-line 
depression treatment (use of an SSRI) versus non-first-line depression 
medication (use of an antidepressant other than an SSRI, use of two or 
more antidepressants, or an antidepressant augmented with lithium or 
an antipsychotic) was derived. The use of non-first-line antidepressant 
medication might indicate either poor response to standard, first-line 
antidepressants (SSRIs), or the need to address complexities in a pa-
tient’s depression presentation (National Institute for Health and Care 
Excellence (NICE), 2009). 
2.3.3. Confounders 
All regression analyses presented were adjusted for sociodemo-
graphic factors associated with depression that might confound associ-
ations (Gilman et al., 2002). The confounders adjusted for were financial 
status and educational attainment (assessed as having attained qualifi-
cations at end of compulsory education, e.g. GCSEs or equivalent qual-
ifications (Yes/No)). 
2.4. Analysis 
2.4.1. Association between ADHD and clinical features of depression 
A series of linear and logistic regression analyses were conducted as 
appropriate to test the association of ADHD symptoms and clinical 
features of depression. Continuous ADHD symptoms were standardised 
(z-scored) so that a one-unit increase was equivalent to one standard 
deviation increase. All regression analyses were then repeated for ADHD 
defined as elevated symptoms, entered as a binary variable instead of a 
continuous variable. This was to test whether the presentation of 
depression was significantly different for those above the AISRS clinical 
cut point for ADHD (≥24) compared to those below the cut-point. 
2.4.2. Missing data 
Regression analyses were repeated with Inverse Probability Weights 
(IPW) applied to assess possible bias arising from potential non-random 
missing data. IPW is a reliable approach to handling missing data, 
particularly in longitudinal cohorts where participants can have missing 
data for multiple variables (Seaman and White, 2013). Weights were 
generated using predictors of missingness from the sample (Supplement 
2). 
3. Results 
In the primary sample of recurrently depressed females (n=148), 
12.8% (n=19) had elevated ADHD symptoms, indicated by having an 
AISRS score above the validated clinical cut point (>24), and 3.4% 
(n=5) met DSM-5 diagnostic criteria for adult ADHD. The lower number 
of those who met diagnostic criteria was explained by participants not 
meeting the age of onset criterion specified in the DSM-5 (<12 years). 
None of the women in the study however, reported having been diag-
nosed with ADHD by a medical professional or receiving medication for 
ADHD. Descriptive statistics are shown in Table 1. 
3.1. Association between ADHD and clinical features of depression 
Standardised ADHD symptoms were associated with an earlier age of 
depression onset (≤ 25 years) and associated severe impairment (GAF ≤
50) (Table 2). ADHD symptoms were also associated with MDD episode 
recurrence over the 13-year period of the study, and persistent sub-
threshold depressive symptoms over the study period. ADHD symptoms 
were associated with increased risk of reporting self-harm or suicide 
attempt during the study period, but were not associated with psychotic 
affective symptoms. ADHD symptoms were associated with higher irri-
tability symptoms. 
In addition, ADHD symptoms were associated with increased odds of 
ever being hospitalised and treatment with a non-first-line antidepres-
sant medication, which may be indicative of poor response to first-line 
antidepressants or a complex clinical presentation. The frequencies of 
different psychotropic medication types used are reported in Supple-
ment 3, which includes depression medication and other 
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neuropsychiatric medications. Of the primary sample (n=148), 63.5% 
(n=94) reported taking psychotropic medication and 19.6% (n=29) 
reported taking more than one psychotropic medication. 
The same associations were tested with ADHD as a binary variable: 
those above the AISRS clinical cut-point for ADHD vs. those below the 
cut-point. Elevated ADHD symptoms were associated with increased 
recurrence of depressive episodes, increased irritability symptoms, 
increased risk of hospitalisation and taking non-first-line depression 
medication. ADHD symptoms above the clinical cut point were also 
associated with a 2-fold increase in odds of early onset depression, but 
this did not reach conventional thresholds for significance. The associ-
ation of elevated ADHD symptoms with severe impairment could not be 
tested, as all participants with elevated ADHD symptoms had had a GAF 
score below or equal to 50, and the association with suicide and self- 
harm attempts could not be tested due to small cell sizes. 
Results remained similar with IPW applied (Supplement 4). How-
ever, the association between total ADHD symptoms and subthreshold 
persistence attenuated after IPW was applied. 
4. Discussion 
In a prospective, longitudinal study of recurrently depressed women, 
we investigated the prevalence of ADHD and the effect of comorbid 
ADHD on the clinical phenotype of depression. In this sample, 12.8% 
had elevated ADHD symptoms and 3.4% met DSM-5 diagnostic criteria 
for ADHD. These are higher than estimates reported in general popu-
lation samples of adults (2.5%) (Simon et al., 2009). None of the par-
ticipants with ADHD had been clinically diagnosed by a medical 
professional. ADHD is not typically assessed in adult clinical settings. 
However, those with high ADHD symptoms were more likely to be 
taking non-first-line antidepressant medication, which might suggest 
that these individuals were recognised by clinicians as having a more 
complex depression presentation or poor response to first-line antide-
pressants (National Institute for Health and Care Excellence (NICE), 
2009). ADHD symptoms were also associated with earlier age of 
depression onset, higher depression associated impairment, a greater 
number of depressive episodes over the study assessment period, 
increased persistence of subthreshold depression symptoms, higher 
levels of irritability, increased odds of self-harm or suicide and increased 
odds of hospitalisation. 
Our findings suggest that a proportion of women in mid-life with a 
history of early-onset, recurrent depression that has been severely 
impairing may have undetected ADHD. Previous studies have shown 
associations of ADHD in childhood and adolescence with more severe 
depressive outcomes in young adulthood, such as depression recurrence, 
suicide and hospitalisation (Biederman et al., 2008; Riglin et al., 2020). 
There is evidence from a national register-based study that those with 
ADHD and depression may be at higher risk of antidepressant treatment 
resistance than those with depression alone (Chen et al., 2016). A 
four-year follow-up study of depressed adults and controls found that 
odds of probable ADHD were higher when depression episodes were 
longer and when participants reported more severe episodes and an age 
of onset of depression before 21 (Bron et al., 2016). However, no studies 
to date have examined recurrently depressed adults, or adults in 
mid-life. Therefore, the present study builds on the existing literature by 
examining the impact of ADHD on a number of different features of 
depression presentation in this recurrently depressed group. This is 
important given the emerging evidence that recurrent adult depression 
may mask underlying neurodevelopmental disorders such as ADHD that 
are missed in clinic (McIntosh et al., 2009). 
There is much heterogeneity observed in the presentation of 
depression (Fried and Nesse, 2015; Kendler et al., 1996; Weissman et al., 
1986), including in its first age-at-onset and chronicity of illness. Our 
results suggest that part of this may be accounted for or indexed by 
comorbid ADHD in some cases. It is possible that some individuals, even 
if they do not fulfil diagnostic criteria for ADHD, have a more ‘neuro-
developmental type’ of depression characterised by early onset, persis-
tence of symptomatology over time and overlap with 
neurodevelopmental traits, including ADHD symptoms (Jaffee et al., 
Table 1 
Descriptive statistics.  
Variable Mean (SD) / % 
(n) 
Range 
ADHD symptoms 11.19 (10.02) 0 - 50 
Age of onset of depression (% onset ≤25 
years) 
26.01 (7.98) / 
45.3% (67) 
8 - 46 
Ever had GAF score ≤ 50 (Severe impairment 
associated with depression) 
73.0% (108) Binary: 0=No, 
1=Yes 
Number of MDD episodes during study 2.42 (1.69) 0 - 7 
Subthreshold depression persistence 1.97 (1.34) 0 - 4 
Ever hospitalised 17.6% (26) Binary: 0=No, 
1=Yes 
Use of non-first-line antidepressants 20.3% (30) Binary: 0=No, 
1=Yes 
Ever attempted self-harm or suicide during 
study 
4.1% (6) Binary: 0=No, 
1=Yes 
Ever had psychotic affective symptoms 
during study 
12.8% (19) Binary: 0=No, 
1=Yes 
Irritability score 2.65 (2.84) 0 - 14 
Descriptive statistics in complete case women (n=148). ADHD attention-deficit/ 
hyperactivity disorder, MDD major depressive disorder, GAF Global Assessment 
of Functioning, SD standard deviation 
Table 2 
Association between adult ADHD symptoms (continuous and dichotomised) and 
clinical features of depression  
Clinical feature of 
depression 
Association with self- 




reported adult ADHD 
symptoms (above 
clinical cut-point versus 
below)  
b or OR 
(95% CI) 
p-value b or OR 
(95% CI) 
p-value 
Depression age of onset of 












0.021 - - - - - 





























Ever attempted self-harm or 
suicide during study 
OR=3.46 
(1.46, 8.21) 
0.005 - - - - - - 
Ever had psychotic affective 











Results in complete case women are shown (n=148). ADHD symptoms were 
dichotomised using the clinical cut point of the Adult ADHD Investigator 
Symptom Rating Scale AISRS (≥24). All participants above the cut point for 
ADHD had had a GAF score below 50, so the association of dichotomised ADHD 
and depression impairment could not be tested due to complete separation is-
sues. The association between dichotomised ADHD and suicide or self-harm 
attempts could not be tested due to small cell sizes. ADHD attention-deficit/ 
hyperactivity disorder, MDD major depressive disorder, GAF Global Assess-
ment of Functioning, b unstandardized beta, CI confidence interval, OR odds 
ratio 
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2002; Rice et al., 2019; van Os et al., 1997). For instance, one study 
found that an earlier onset, more chronic class of depressive symptoms 
from childhood to early adulthood (age 18) was associated with more 
neurodevelopment traits (ADHD, pragmatic language skills and autistic 
traits) and ADHD genetic risk scores (Rice et al., 2019). Other studies 
also suggest that the genetic architecture of earlier onset depression may 
be more neurodevelopmental in nature and tends to be more strongly 
associated with neurodevelopmental genetic risk (Musliner et al., 2019; 
Power et al., 2017; Thapar and Riglin, 2020). The present study is 
important and novel because it examines women in mid-life with 
recurrent diagnosed depression from a longitudinal cohort spanning 13 
years. It is important to note that those with early onset depression may 
have symptoms that desist by early adulthood or persist into adulthood 
(e.g. Jaffee et al., 2002). In the present study of recurrently depressed 
adults, age of depression onset is measured using retrospective report. 
This might affect results by capturing a specific, persistent subgroup of 
those with early onset depression. 
Our findings have important clinical implications. They suggest that 
in women with early onset, recurrent depression in adulthood, the 
possibility of depression masking underlying ADHD needs to be 
considered. Effective treatment of ADHD along with depression could 
improve functioning and associated depression symptoms (Chang et al., 
2016). Even for those who do not meet diagnostic criteria for ADHD, 
higher ADHD symptoms appear to index a worse clinical picture. It is 
possible that they represent a ‘neurodevelopmental type’ of depression 
presentation, including earlier age of onset, increased severity and 
recurrence and more prominent irritability. Therefore, they may require 
more frequent follow-up or different types of management for depres-
sion. It will be important for future studies to examine whether this 
group might respond to different types of depression treatment to those 
that are typically used for depression such as cognitive behavioural 
therapy and SSRI antidepressants. 
Limitations of this work include the measurement of ADHD was 
based on a questionnaire measure completed at one assessment wave. 
Also, in this study we focussed on women with adolescent children who 
had participated in a longitudinal study of recurrent depression so the 
findings may not apply to males or other groups, for example, hospi-
talised patients. The rate of ADHD observed may be influenced by spe-
cific characteristics of the present sample. Rates of ADHD may be higher 
in this sample because individuals all had recurrent depression. How-
ever, given that ADHD is associated with multiple social and educational 
impairments (Harpin, 2005), those with comorbid ADHD also may be 
under-represented in this sample. As age of onset was reported retro-
spectively in this study, results may be affected by recall bias (Drews and 
Greeland, 1990). In addition, the retrospective data did not allow for 
reliable differentiation between childhood, adolescent or early adult-
hood onset depression within the early-onset group, which have been 
found to behave differently in terms of associations and persistence 
when age of onset is inferred using prospectively collected data (Rice 
et al., 2019). Overall comorbidity as opposed to comorbidity with ADHD 
specifically may have contributed to results. Indeed, we observed high 
rates of co-occurring anxiety symptoms in the recurrently depressed 
adults with ADHD symptoms, which is consistent with previous studies 
that report high rates of comorbidity of ADHD with both anxiety and 
with depression (Kessler et al., 2006). However, when adjusting our 
regressions for anxiety symptoms, results remained very similar (Sup-
plement 5), suggesting the impact of ADHD on depression presentation 
is still observed when accounting for other comorbidity. It is also 
important to note that although use of non-first-line antidepressant 
medication can indicate poor response to first-line antidepressants or a 
complex clinical presentation, there may be other reasons that a 
non-first-line antidepressant is prescribed, for example, experience of 
side effects. As is common in longitudinal cohort studies, there was some 
attrition of the sample over time. Analysis of baseline factors associated 
with drop-out at wave 4 (Supplement 4), showed that while factors such 
as lower socioeconomic status and education were associated with 
attrition, other factors associated with severity of depression and history 
of depression treatment were not. These included the percentage of the 
participant’s life that they had been unwell since depression onset and 
previous non-pharmacological treatment for depression (including 
talking therapies and electroconvulsive therapy). This might suggest 
that those with more severe depression or a history of depression 
treatment may be more likely to stay in the current study, which is likely 
due to the inclusion criteria of the EPAD study, namely that the 
participant had experienced at least 2 prior episodes of depression. 
Nevertheless, to account for any potential bias arising from attrition, 
analyses were adjusted for variables associated with missingness, help-
ing to address potential bias due to missing data (Groenwold et al., 
2012). In addition, regression results when inverse probability weights 
were applied remained similar, suggesting bias due to missingness was 
minimal (Supplement 3) (Seaman and White, 2013). 
To conclude, we found that in a sample of recurrently depressed 
adults, ADHD was associated with an earlier onset, more impairing and 
recurrent depression presentation, in addition to increased risk of self- 
harm, hospitalisation and receiving non-first-line antidepressant medi-
cation. Higher ADHD symptoms appear to index a worse clinical pre-
sentation for depression. Findings suggest that in women with early 
onset, recurrent depression, the possibility of underlying ADHD masked 
by depression needs to be considered. It is also possible that specifically 
treating ADHD symptoms in women with recurrent depression will 
improve long-term clinical outcomes. 
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